Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forodesine in Pediatric Relapsed/Refractory ALL and T-NHL
NCT00742495Phase 2Terminated
- Sponsor
- Mundipharma
- Start
- Mar 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of forodesine in t-cell acute lymphoblastic leukemia (T-ALL), acute lymphoblastic leukemia (ALL), T-cell non-Hodgkin lymphoma, sponsored by Mundipharma. Started Mar 2009; status: terminated.
02
Drugs
forodesine
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)acute lymphoblastic leukemia (ALL)T-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00742495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742495.